News

NatWest returns to private ownership for first time since 2008 rescue
(Alliance News) - The UK government has sold its remaining shares in NatWest Group PLC and confirmed a GBP10.5 billion loss since the bank was rescued by UK taxpayers during the 2008 financial crisis.
EARNINGS: Surgical Innovations loss widens; Arrow revenue up
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: ...
Invinity remains confident in future growth despite revenue dive
The Saint Helier, Channel Islands-based firm makes vanadium batteries VS3 and Endurium, which are used to store renewable energy. Invinity posted annual revenue of GBP5 million, down 77% from GBP22 ...
JPMorgan Asia Growth outperforms benchmark but interim return negative
NAV total return was minus 1.1% in the six months to March 31, beating its benchmark, the MSCI AC Asia excluding Japan, which had a return of minus 2.2%.
hVIVO stock plunges after contract cancellations in "depressed" market
hVIVO has GBP47 million in revenue contracted for financial 2025, inclusive of cancellation and postponement fees, and anticipates further contract wins during the year. The company said it is in ...
DIRECTOR DEALINGS: Rolls-Royce, FBD and AJ Bell execs sell shares
AJ Bell PLC - Manchester-based retail investment platform - Billy Mackay, managing director of Advised business, sells 39,922 shares at GBP5.01, worth GBP200,005, on Wednesday. Mackay now has 1.3 ...
M&G shares up as Dai-ichi Life aims to buy 15% stake amid partnership
Dai-ichi also intends to acquire around a 15% stake in M&G, which upon completion would give Dai-ichi the right to appoint a director to the board of M&G. "It is expected that M&G will be an affiliate ...
Danaher partners with AstraZeneca to develop AI diagnostics
Danaher Corp on Thursday said it has entered a partnership with AstraZeneca PLC to develop and commercialise tools and tests for precision medicine treatments, including artificial intelligence ...
RTW Biotech notes mixed updates across portfolio companies
Meanwhile, Merus, a Netherlands-based cancer cure developer, saw its shares jump after unveiling interim phase 2 data for its experimental antibody petosemtamab in combination with pembrolizumab for ...
SMALL-CAP WINNERS & LOSERS: Alpha Group extends Corpay bid deadline
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.
LONDON BROKER RATINGS: 'buy' Beazley and Hiscox, 'hold' Lancashire
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Aptamer cheers second product development deal with Unilever
Aptamer's binders are essentially synthetic antibodies, attaching to targets in the body. The binders developed by Aptamer in its first contract with Unilever have passed the lab-testing phase, with ...